The Influence of Demographic and Socioeconomic Factors on the Appropriate Use of Aspirin Therapy

Existing research has shown aspirin therapy to be an effective preventive measure for cardiovascular disease in both individuals who have experienced a previous cardiovascular event and in those that are at an elevated risk to do so. Both the American Heart Association and the United States Preventive Services Task Force have recommended regular aspirin therapy for all individuals with existing cardiovascular disease, as well as individuals who present an elevated risk for a future cardiovascular event. However, existing research suggests that the actual use of aspirin as a preventive treatment is alarmingly low, and may be affected by age, race, gender, and socioeconomic status. In this study, the influence of demographic and socioeconomic factors on the effective use of aspirin as a preventive treatment for cardiovascular disease was examined. Results suggest that while women and younger individuals do use daily aspirin to a lesser extent, they are actually more likely to follow the proper course of preventive action according to established guidelines. Race and income influenced the use of aspirin therapy to a lesser extent than in other studies, and this lends support to the theory that quality of medical care is a source of the socioeconomic difference in preventive medicine. Results identify specific groups of individuals that may benefit from aspirin intervention and education programs.Partnership for PreventionNo embarg